Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Aug-24 4:51 PM View:  | Gordon Christopher R Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition Duplicate | 65,679,800 | -- | -- | (100%) 65.68M to 0 | |
| 05-Aug-24 4:49 PM View: | Koppel Adam Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 13,743 | -- | -- | (< 1%) 65.69M to 65.68M | |
| 05-Aug-24 4:36 PM View: | Giordano Douglas E. Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 13,743 | -- | -- | (100%) 13.74K to 0 | |
| 05-Aug-24 4:36 PM View: | Renaud Ronald C Jr President & CEO Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 83,857 | -- | -- | (100%) 83.86K to 0 | |
| 05-Aug-24 4:20 PM View: | Burgess Paul D. See Remarks | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 45,727 | -- | -- | (100%) 45.73K to 0 | |
| 05-Aug-24 6:25 PM View: | Pfizer Inc | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition (change in control) | 27,349,200 | $45.00 | $1,230,710,016.00 | (100%) 27.35M to 0 | |
| 05-Aug-24 4:34 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 7,527 | -- | -- | (100%) 7.53K to 0 | |
| 05-Aug-24 4:49 PM View: | Koppel Adam Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 65,679,800 | -- | -- | (100%) 65.68M to 0 | |
| 05-Aug-24 4:32 PM View: | Greene Gabrielle E Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 58,876 | -- | -- | (100%) 58.88K to 0 | |
| 05-Aug-24 4:34 PM View: | McKernan Ruth Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 13,743 | -- | -- | (100%) 13.74K to 0 | |
| 05-Aug-24 4:30 PM View: | Renger John Chief Scientific Officer | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 6,370 | -- | -- | (100%) 6.37K to 0 | |
| 05-Aug-24 4:38 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 14,673 | -- | -- | (100%) 14.67K to 0 | |
| 05-Aug-24 4:51 PM View: | Gordon Christopher R Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 13,743 | -- | -- | (< 1%) 65.69M to 65.68M | |
| 05-Aug-24 4:21 PM View: | Patrick Deval L Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 13,743 | -- | -- | (100%) 13.74K to 0 | |
| 05-Aug-24 4:36 PM View: | Renaud Ronald C Jr President & CEO Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 160,452 | -- | -- | (66%) 244.31K to 83.86K | |
| 05-Aug-24 4:20 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition | 25,928 | -- | -- | (100%) 25.93K to 0 | |
| 05-Aug-24 4:52 PM View: | Bain Capital Investors LLC Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 01-Aug-24 | Disposition Duplicate | 65,679,800 | -- | -- | (100%) 65.68M to 0 | |
| 07-Jun-24 4:28 PM View: | Greene Gabrielle E Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 22% 48.41K to 58.88K | |
| 07-Jun-24 4:27 PM View: | McKernan Ruth Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 319% 3.28K to 13.74K | |
| 07-Jun-24 4:30 PM View: | Riedel Norbert G Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 23% 46.09K to 56.55K | |
| 07-Jun-24 5:22 PM View: | Gordon Christopher R Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | < 1% 65.68M to 65.69M | |
| 07-Jun-24 4:34 PM View: | Patrick Deval L Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 319% 3.28K to 13.74K | |
| 07-Jun-24 4:34 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,290 | -- | -- | 66% 15.64K to 25.93K | |
| 07-Jun-24 4:34 PM View: | Dekkers Marijn E Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 2% 434.15K to 444.61K | |
| 07-Jun-24 5:12 PM View: | Koppel Adam Director 10% Owner | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | < 1% 65.68M to 65.69M | |
| 07-Jun-24 4:30 PM View: | Giordano Douglas E. Director | Cerevel Therapeutics Holdin... (CERE) | 05-Jun-24 | Grant | 10,461 | -- | -- | 319% 3.28K to 13.74K | |
| 05-Jun-24 4:05 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 03-Jun-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 05-Jun-24 4:05 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 03-Jun-24 | Planned Option Sale | 50,000 | $40.61 | $2,030,520.00 | (76%) 65.64K to 15.64K | |
| 14-May-24 5:16 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 10-May-24 | Planned Option Sale | 50,000 | $42.10 | $2,105,120.00 | (76%) 65.64K to 15.64K | |
| 14-May-24 5:16 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 10-May-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 03-Apr-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 01-Apr-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 03-Apr-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 01-Apr-24 | Planned Option Sale | 50,000 | $42.33 | $2,116,640.00 | (76%) 65.64K to 15.64K | |
| 06-Mar-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 04-Mar-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 06-Mar-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 04-Mar-24 | Planned Option Sale | 50,000 | $41.01 | $2,050,550.00 | (76%) 65.64K to 15.64K | |
| 04-Mar-24 5:49 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 29-Feb-24 | Planned Option Sale | 50,000 | $41.16 | $2,057,890.00 | (76%) 65.64K to 15.64K | |
| 04-Mar-24 5:49 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 29-Feb-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 320% 15.64K to 65.64K | |
| 21-Feb-24 4:54 PM View: | Perceptive Advisors LLC Director | Cerevel Therapeutics Holdin... (CERE) | 20-Feb-24 | Gift | 170,317 | -- | -- | (2%) 10.97M to 10.79M | |
| 08-Feb-24 7:19 PM View: | Renger John Chief Scientific Officer | Cerevel Therapeutics Holdin... (CERE) | 07-Feb-24 | Option Sale | 2,161 | $41.54 | $89,776.80 | (25%) 8.53K to 6.37K | |
| 08-Feb-24 7:14 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 07-Feb-24 | Option Sale | 2,506 | $41.54 | $104,110.00 | (14%) 18.14K to 15.64K | |
| 08-Feb-24 7:14 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 06-Feb-24 | Option Exercise | 15,440 | -- | -- | 571% 2.7K to 18.14K | |
| 08-Feb-24 7:19 PM View: | Renger John Chief Scientific Officer | Cerevel Therapeutics Holdin... (CERE) | 06-Feb-24 | Option Exercise | 5,020 | -- | -- | 143% 3.51K to 8.53K | |
| 04-Jan-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 02-Jan-24 | Option Exercise | 50,000 | $3.50 | $175,000.00 | 1849% 2.7K to 52.7K | |
| 04-Jan-24 4:15 PM View: | Coles N Anthony Director | Cerevel Therapeutics Holdin... (CERE) | 02-Jan-24 | Planned Option Sale | 50,000 | $42.24 | $2,111,820.00 | (95%) 52.7K to 2.7K | |
| 28-Dec-23 4:15 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 26-Dec-23 | Planned Option Sale | 10,000 | $42.47 | $424,700.00 | (41%) 24.67K to 14.67K | |
| 28-Dec-23 4:15 PM View: | Sanchez Ramiro Chief Medical Officer | Cerevel Therapeutics Holdin... (CERE) | 26-Dec-23 | Option Exercise | 10,000 | $3.50 | $35,000.00 | 68% 14.67K to 24.67K | |
| 28-Dec-23 4:15 PM View: | Tregoning Kathleen See Remarks | Cerevel Therapeutics Holdin... (CERE) | 26-Dec-23 | Option Exercise | 3,150 | $10.05 | $31,657.50 | 42% 7.52K to 10.67K | |
| 27-Dec-23 4:15 PM View: | Dipietro Kenneth Chief Human Resources Officer | Cerevel Therapeutics Holdin... (CERE) | 22-Dec-23 | Option Exercise | 8,000 | $3.50 | $28,000.00 | 32% 24.66K to 32.66K | |
| 27-Dec-23 4:15 PM View: | Dipietro Kenneth Chief Human Resources Officer | Cerevel Therapeutics Holdin... (CERE) | 22-Dec-23 | Option Sale | 8,000 | $41.45 | $331,608.00 | (24%) 32.66K to 24.66K | |
| 21-Dec-23 8:21 PM View: | Akamine Scott Chief Legal Officer | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 7,072 | $41.42 | $292,945.00 | (49%) 14.31K to 7.24K | |
| 21-Dec-23 8:10 PM View: | Tregoning Kathleen See Remarks | Cerevel Therapeutics Holdin... (CERE) | 20-Dec-23 | Option Sale | 6,288 | $41.42 | $260,469.00 | (46%) 13.8K to 7.52K |
